This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Doctor Reddy's (RDY) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies
by Zacks Equity Research
Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies are part of the Zacks Industry Outlook article.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
by Sundeep Ganoria
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, AMPH and SLGL.
Dr. Reddy's (RDY) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Dr. Reddy's (RDY) reports better-than-expected fiscal second-quarter 2024 results where both earnings and revenues beat estimates, driven by growth in core businesses in North America and Europe.
All You Need to Know About Doctor Reddy's (RDY) Rating Upgrade to Strong Buy
by Zacks Equity Research
Doctor Reddy's (RDY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks.com featured highlights Marathon Oil, Dr. Reddy's Laboratories, American Eagle, Peabody Energy and Skechers USA
by Zacks Equity Research
Marathon Oil, Dr. Reddy's Laboratories, American Eagle, Peabody Energy and Skechers USA have been highlighted in this Screen of The Week article.
5 Top-Ranked Stocks With Compelling Relative Price Strength
by Nilanjan Choudhury
MRO. RDY, AEO, BTU and SKX are five stocks with explosive relative price strength.
Here's Why Doctor Reddy's (RDY) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Reasons Growth Investors Will Love Doctor Reddy's (RDY)
by Zacks Equity Research
Doctor Reddy's (RDY) could produce exceptional returns because of its solid growth attributes.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Analyst Blog Highlights Molina Healthcare, Dr. Reddy's Laboratories and NeuroBo Pharmaceuticals
by Zacks Equity Research
Molina Healthcare, Dr. Reddy's Laboratories and NeuroBo Pharmaceuticals are part of the Zacks top Analyst Blog.
Protect Your Portfolio From Volatility With 3 Low-Beta Picks
by Indrajit Bandyopadhyay
At this stage, it is prudent to invest in low-beta stocks with a favorable Zacks Rank like ALC, RDY and ANIK, as these will be less volatile than the broader market.
Want to Shrug Off Volatility? Buy 3 Medical Growth Stocks
by Indrajit Bandyopadhyay
We pick three medical stocks - MOH, RDY and NRBO - that have gained more than 5% in the past three months amid market volatility.
Doctor Reddy's (RDY) Loses -6.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Doctor Reddy's (RDY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Why Doctor Reddy's (RDY) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Strength Seen in Bausch (BHC): Can Its 8.0% Jump Turn into More Strength?
by Zacks Equity Research
Bausch (BHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Navigate Volatility With These 3 Low-Beta Stocks
by Derek Lewis
Low-beta stocks can provide many beneficial advantages for investors, including a more defensive nature and overall portfolio balance.
Discount Alert: 3 Top Ranked Stocks Trading Below Historical Valuations
by Ethan Feller
While the headlines often spotlight stocks that are soaring to new heights, some of the best investment prospects lie in stocks trading below their historical valuations
Here is Why Growth Investors Should Buy Doctor Reddy's (RDY) Now
by Zacks Equity Research
Doctor Reddy's (RDY) could produce exceptional returns because of its solid growth attributes.
Zacks.com featured highlights Caterpillar, KB Home, Walmart, Dr. Reddy's Laboratories and FedEx
by Zacks Equity Research
Caterpillar, KB Home, Walmart, Dr. Reddy's Laboratories and FedEx have been highlighted in this Screen of The Week article.
5 Dividend Growth Stocks for Steady Returns in Uncertain Times
by Sweta Killa
Caterpillar (CAT), KB Home (KBH), Walmart (WMT), Dr. Reddy's (RDY) and FedEx (FDX) could be solid choices amid the current market volatility.
These 3 Low-Beta Stocks Sport High Growth
by Derek Lewis
Low-beta stocks can provide many beneficial advantages for investors, including a more defensive nature and overall portfolio balance. And for those seeking this approach, these three stocks are great considerations.